Skip to Main content Skip to Navigation
Journal articles

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

Pascale Tomasini 1 Solenn Brosseau 2, 3 Julien Mazières 4 Jean Merlio 5, 6 Michèle Beau-Faller 7 Jean Mosser 8 Marie Wislez 9 l'Houcine Ouafik 10, 11 Benjamin Besse 12 Isabelle Rouquette 13 Didier Debieuvre 14 Fabienne Escande 15 Virginie Westeel 16 Clarisse Audigier-Valette 17 Pascale Missy 18 Alexandra Langlais 19 Frank Morin 19 Denis Moro-Sibilot 20 Gérard Zalcman 21 Fabrice Barlesi 1
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01699297
Contributor : l'Houcine Ouafik <>
Submitted on : Friday, February 2, 2018 - 11:09:22 AM
Last modification on : Thursday, October 8, 2020 - 3:07:03 AM

Links full text

Identifiers

Citation

Pascale Tomasini, Solenn Brosseau, Julien Mazières, Jean Merlio, Michèle Beau-Faller, et al.. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. European Respiratory Journal, European Respiratory Society, 2017, 50 (2), pii: 1700514. ⟨10.1183/13993003.00514-2017⟩. ⟨hal-01699297⟩

Share

Metrics

Record views

536